WASHINGTON – US health authorities at Food and Drug Administration (FDA) have said that data provided by Moderna on the efficacy of its Covid-19 vaccine among young kids were accurate, ahead of a decision this week if it can be authorize two inoculations against the virus in kids aged six months to five years. The  FDA said vaccine efficacy against …